Sign Out
Pregnancy: Rosuvastatin is contraindicated in women who are or may become pregnant.
Rosuvastatin may cause fetal harm when administered to a pregnant woman. If the patient becomes pregnant while taking Rosuvastatin, the patient should be apprised of the potential risks to the fetus and the lack of known clinical benefit with continued use during pregnancy.
Lactation: Distributed into milk in animals; not known whether rosuvastatin is distributed into milk in humans.
Discontinue nursing or drug, taking into account the importance of the drug to the woman.
